Again, RP-B7-H3 CAR T treatment resulted in complete tumor regression in 100% of mice while NRP-B7-H3 CAR T treatment inhibited tumor growth significantly but did not cause complete tumor regression (Supplementary Fig. 6b). This evidence concerns the gene CD80 and neoplasm.